Prepare for the 2013-2014 Influenza Season
Thank you from VNAA Platinum Partner VaxServe
Friday, September 27, 2013
by: VaxServe

Section: Corporate Partners

Sponsored by


A Sanofi Pasteur Company

VaxServe® remains committed to helping VNAA members provide their patients with Fluzone® influenza virus vaccine each flu season. While preparing for the 2013-2014 season, here are a few reminders of why Fluzone is the influenza vaccine of choice and VaxServe is the product distributor of choice. 
  • Sanofi Pasteur: Incomparable track record and experience
    • 40 years of experience producing Fluzone vaccine
    • Continually meeting customer commitments with quantity requested and delivery times
  • Sanofi Pasteur: Unrivaled capacity
    • Two US influenza vaccine manufacturing facilities
    • Capacity to manufacture up to 150 million total doses of trivalent inactivated vaccine
  • Sanofi Pasteur: Unmatched portfolio
    • Indication starting at six months of age
    • Robust pipeline including quadrivalent and universal vaccines
    • Continued investigation of new technologies, innovative products, and manufacturing efficiencies
  • VaxServe: Specialty distributor that focuses on vaccines
    • Relationship with Sanofi Pasteur, manufacturer of Fluzone vaccine 
    • Representatives available to answer any questions about Fluzone vaccine
Sanofi Pasteur and VaxServe remain the market leaders through the 2013-2014 influenza season. Thank you again for working with us during the upcoming influenza season.
Post a Comment